RNA INTERFERENCE-MEDIATED INHIBITION OF TMPRSS6
CY1125760T1Undetermined Publication Date: 2026-04-17SILENCE THERAPEUTICS GMBH
0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100038T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-11-13
- Filing Date
- 2023-01-24
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2043-01-24
Abstract
The present invention relates to products and compositions and their uses. In particular, the invention relates to nucleic acid products that interfere with the expression of the TMPRSS6 gene or inhibit its expression and to therapeutic uses such as for the treatment of hemochromatosis, porphyria and hematological disorders such as β-thalassemia, sickle cell disease and iron overload from transfusions or myelodysplastic syndrome.
Need to check novelty before this filing date? Find Prior Art